Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway

Published:2020-07 Issue: Volume:127 Page:110223
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Ye Jiwei,Gao Mingquan,Guo Xinwu,Zhang Henan,Jiang Fuchun

Funder

Youth Talent Development Plan of Shanghai Municipal Agricultural System of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference46 articles.

1. Prostate cancer;Attard;Lancet,2016

2. Treatment effects in prostate cancer;Evans;Mod. Pathol.,2018

3. New treatment developments applied to elderly patients with advanced prostate cancer;Mukherji;Cancer Treat. Rev.,2013

4. Treatments for metastatic prostate Cancer (mPC): a review of costing evidence;Norum;Pharmacoeconomics,2017

5. Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches;Doldi;Cell. Mol. Life Sci.,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breviscapine ameliorates autophagy by activating the JAK2/STAT5/BCL2 pathway in a transient cerebral ischemia rat model;Journal of Neuropathology & Experimental Neurology;2024-05-28

2. PAQR4 oncogene: a novel target for cancer therapy;Medical Oncology;2024-05-20

3. Ultrasound image-guided cancer gene therapy using iRGD dual-targeted magnetic cationic microbubbles;Biomedicine & Pharmacotherapy;2024-03

4. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation;European Journal of Pharmacology;2023-09

5. Breviscapine reverses doxorubicin resistance in breast cancer and its related mechanisms;Thoracic Cancer;2023-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3